Concepedia

Cecelia Miller

CM

12

Publications

387

Citations

11

H-Index

2015

Active since

Affiliations

The Ohio State University(Current)

University of Cincinnati

Dana-Farber Cancer Institute

The Ohio State University Wexner Medical Center

The University of Texas MD Anderson Cancer Center

Cecelia Miller is an author at The Ohio State University specializing in medicine, genomics, and cancer research.

ORCID

Top concepts

Publications per year

2015–2024

12

Publications

12

<i>TCL1</i> targeting <i>miR-3676</i> is codeleted with tumor protein p53 in chronic lymphocytic leukemia

Veronica Balatti, Lara Rizzotto, Cecelia Miller et al. · Proceedings of the National Academy of Sciences · 2015 · 72 citations · Full text

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib

Adam S. Kittai, Cecelia Miller, Daniel Goldstein et al. · Blood · 2021 · 57 citations

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema et al. · Blood Advances · 2017 · 44 citations · Full text

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

Jennifer A. Woyach, Gabriela Perez Burbano, Amy S. Ruppert et al. · Blood · 2024 · 43 citations · Full text

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study

Adam S. Kittai, David A. Bond, Ying Huang et al. · Journal of Clinical Oncology · 2024 · 41 citations

Rows per page

1–5 of 12